71 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Bristol-Myers Squibb Pharmaceutical Research Institute
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-car![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Warner-Lambert
Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Smithkline Beecham Pharmaceuticals
Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Searle R & D and Mcr
Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
E. I. Du Pont De Nemours
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Warner-Lambert
Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
E. I. Du Pont De Nemours And
The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
E. I. Du Pont De Nemours
Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Washington State University
Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Donghua University
Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Uppsala University
Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
The University of Mississippi
Design, synthesis, and biological evaluation of AT1 angiotensin II receptor antagonists based on the pyrazolo[3,4-b]pyridine and related heteroaromatic bicyclic systems.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Universit£
2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Abbott Laboratories
4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridines: potent arylacetic acid-derived AT1 antagonists with improved affinity for the AT2 receptor![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
The SAR of 6-(N-alkyl-N-acyl)-2-propyl-3-[(2′-tetrazol-5-yl)biphen-4-yl)methyl]-quinazolinones as balanced affinity antagonists of the human AT1 and AT2 receptors![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Balanced angiotensin II receptor antagonists. I. The effects of biphenyl “ortho”-substitution on AT1/AT2 affinities![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Synthesis and biological evaluation of the potent isoxazolidinyl angiotensin II receptor antagonist CL332,877 and its enantiomers.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
6-isoxazolinyl and isoxazolidinyl substituted quinazolinones as angiotensin II receptor antagonists![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
TBA
Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Uppsala University
Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Uppsala University
Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Bristol-Myers Squibb Pharmaceutical Research Institute
Specific nonpeptide photoprobes as tools for the structural study of the angiotensin II AT(1) receptor.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Laboratoires Fournier
The Other Angiotensin II Receptor: AT![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil
Multiple binding modes for the receptor-bound conformations of cyclic AII agonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Washington University
A novel series of selective, non-peptide inhibitors of angiotensin II binding to the AT2 site.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Dupont Pharmaceuticals
Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
University of Innsbruck
Angiotensin II analogues encompassing 5,9- and 5,10-fused thiazabicycloalkane tripeptide mimetics.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Uppsala University
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Wyeth-Ayerst Research
Design, synthesis, and biological activities of four angiotensin II receptor ligands with gamma-turn mimetics replacing amino acid residues 3-5.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Uppsala University
4-(Heteroarylthio)-2-biphenylyltetrazoles as nonpeptide angiotensin II antagonists.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Burroughs Wellcome
4-Diazinyl- and 4-pyridinylimidazoles: potent angiotensin II antagonists. A study of their activity and computational characterization.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Laboratori Guidotti
Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Hoechst Roussel Pgu Cardiovascular Agents
Nonpeptide angiotensin II receptor antagonists. Synthesis, in vitro activity, and molecular modeling studies of N-[(heterobiaryl)methyl] imidazoles.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Istituto Lusofarmaco
Bromobenzofuran-based non-peptide antagonists of angiotensin II: GR138950, a potent antihypertensive agent with high oral bioavailability.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Glaxo Research and Development
Conformational restriction of angiotensin II: cyclic analogues having high potency.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
G.D. Searle And
Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.![EBI](/images/logo_chembl.png)
![EBI](/images/logo_chembl.png)
Smithkline Beecham Pharmaceuticals